Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Amylyx Pharmaceuticals, Inc. (AMLX)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 67,520,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Amylyx Pharmaceuticals is engaged in the development of therapies that change the treatment paradigm for amyotrophic lateral sclerosis, and a range of neurodegenerative diseases. Co. is pursuing commercialization of its product candidate, AMX0035, which is a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and tauroursodeoxycholic acid. Co. is also developing AMX0035 for other neurodegenerative diseases including Alzheimer's Disease, Wolfram syndrome, Parkinson's Disease, Huntington's Disease, Progressive Supranuclear Palsy, Multi-System Atrophy, primary lateral sclerosis, ischemic stroke, Friedreich's ataxia, Leigh's syndrome and Leber's hereditary optic neuropathy.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 4,000 4,000 5,000
Total Buy Value $0 $59,880 $59,880 $91,870
Total People Bought 0 1 1 1
Total Buy Transactions 0 1 1 2
Total Shares Sold 14,440 31,650 82,279 2,678,586
Total Sell Value $270,512 $551,518 $1,903,013 $81,903,056
Total People Sold 4 5 5 10
Total Sell Transactions 5 9 12 39
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 91
  Page 3 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Olinger Margaret Chief Commercial Officer   •       –      –    2023-03-16 4 A $0.00 $0 D/D 18,333 232,688     -
   Yeramian Patrick D Chief Medical Officer   •       –      –    2023-03-16 4 A $0.00 $0 D/D 9,167 158,839     -
   Yeramian Patrick D Chief Medical Officer   •       –      –    2023-03-16 4 AS $31.85 $1,741,200 D/D (54,627) 149,672     -
   Morningside Venture Investments Ltd 10% Owner   –       –       •   2023-03-16 4 S $32.55 $296,921 D/D (9,122) 7,250,762     -
   Morningside Venture Investments Ltd 10% Owner   –       –       •   2023-03-15 4 S $33.12 $4,990,997 D/D (150,000) 7,259,884     -
   Morningside Venture Investments Ltd 10% Owner   –       –       •   2023-03-14 4 S $34.54 $2,442,462 D/D (70,714) 7,409,884     -
   Morningside Venture Investments Ltd 10% Owner   –       –       •   2023-03-02 4 S $33.75 $1,687,500 D/D (50,000) 7,480,598     -
   Mazzariello Gina Chief Legal Officer   •       –      –    2023-02-24 4 AS $34.49 $123,672 D/D (3,586) 37,414     -
   Morningside Venture Investments Ltd 10% Owner   –       –       •   2023-02-23 4 S $35.55 $1,778,267 D/D (50,000) 7,580,598     -
   Morningside Venture Investments Ltd 10% Owner   –       –       •   2023-02-22 4 S $34.70 $1,736,352 D/D (50,000) 7,530,598     -
   Morningside Venture Investments Ltd 10% Owner   –       –       •   2023-02-22 4 S $35.91 $1,799,836 D/D (50,000) 7,630,598     -
   Klee Justin B. Co-Chief Executive Officer   •       •      –    2023-01-06 4 S $36.08 $216,629 D/D (5,968) 2,892,617     -
   Olinger Margaret Chief Commercial Officer   •       –      –    2023-01-06 4 S $36.08 $87,225 D/D (2,403) 214,355     -
   Cohen Joshua B Co-Chief Executive Officer   •       •      –    2023-01-06 4 S $36.08 $216,629 D/D (5,968) 2,892,617     -
   Yeramian Patrick D Chief Medical Officer   •       –      –    2023-01-06 4 S $36.08 $73,831 D/D (2,034) 204,299     -
   Frates James M Chief Financial Officer   •       –      –    2023-01-06 4 S $36.08 $96,481 D/D (2,658) 34,009     -
   Frates James M Chief Financial Officer   •       –      –    2022-12-30 4 OE $6.88 $34,400 D/D 5,000 36,667     -
   Dragsa 96 Llc   •       •       •   2022-09-09 4 S $29.87 $21,159,753 I/I (700,000) 1,850,940     -
   Dragsa 96 Llc   •       •       •   2022-09-08 4 S $27.28 $20,559,887 I/I (700,000) 2,075,470     -
   Als Invest 1 B.v. 10% Owner   –       –       •   2022-07-06 4 S $19.54 $1,254,642 D/D (60,609) 5,895,280     -
   Mazzariello Gina Chief Legal Officer   •       –      –    2022-02-22 4 A $0.00 $0 D/D 41,000 41,000     -
   Mvil, Llc 10% Owner   –       –       •   2022-01-11 4/A B $19.00 $5,000,002 I/I 263,158 10,678,808 1.5     -
   Mvil, Llc 10% Owner   –       –       •   2022-01-11 4/A A $0.00 $0 I/I 10,415,650 10,415,650     -
   Morningside Venture Investments Ltd 10% Owner   –       –       •   2022-01-11 4 B $19.00 $5,000,002 D/D 263,158 10,678,808 2.45     -
   Morningside Venture Investments Ltd 10% Owner   –       –       •   2022-01-11 4 A $0.00 $0 D/D 10,415,650 10,415,650     -
  91 Records found
  1  2  3  4   
  Page 3 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us